Fulcrum Therapeutics, Inc. (FULC)

11.07 +0.65 (+6.24%) USD  |  NASDAQ  |  Jan 22, 16:00
11.07 0.00 (0.00%) After-Hours: 19:36
More

Fulcrum Therapeutics Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
Biogen, Inc. Upgrade
CorMedix, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade